Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Clinical evaluation of deep learning‐enhanced lymphoma pet imaging with accelerated acquisition

作者:Xu Li, Boyang Pan, Congxia Chen, Dongyue Yan, Zhenglin Pan, Tao Feng, Hui Liu, Nan‐Jie Gong, Fugeng Liu · 发表于:Journal of Applied Clinical Medical Physics · 年份:2024 · DOI:10.1002/acm2.14390 · 被引用次数:5 · 研究领域:Medical Imaging Techniques and Applications、Radiomics and Machine Learning in Medical Imaging、Lung Cancer Diagnosis and Treatment

Abstract Purpose This study aims to evaluate the clinical performance of a deep learning (DL)‐enhanced two‐fold accelerated PET imaging method in patients with lymphoma. Methods A total of 123 cases devoid of lymphoma underwent whole‐body 18F‐FDG‐PET/CT scans to facilitate the development of an advanced SAU2Net model, which combines the advantages of U2Net and attention mechanism. This model integrated inputs from simulated 1/2‐dose (0.07 mCi/kg) PET acquisition across multiple slices to generate an estimated standard dose (0.14 mCi/kg) PET scan. Additional 39 cases with confirmed lymphoma pathology were utilized to evaluate the model's clinical performance. Assessment criteria encompassed peak‐signal‐to‐noise ratio (PSNR), structural similarity index (SSIM), a 5‐point Likert scale rated by two experienced physicians, SUV features, image noise in the liver, and contrast‐to‐noise ratio (CNR). Diagnostic outcomes, including lesion numbers and Deauville score, were also compared. Results Images enhanced by the proposed DL method exhibited superior image quality ( P < 0.001) in comparison to low‐dose acquisition. Moreover, they illustrated equivalent image quality in terms of subjective image analysis and lesion maximum standardized uptake value (SUVmax) as compared to the standard acquisition method. A linear regression model with y = 1.017x + 0.110 () can be established between the enhanced scans and the standard acquisition for lesion SUVmax. With enhancement, increased sig...